|
IAC Express 2006 |
| Issue number 637: December 18, 2006 |
| |
Contents
of this Issue
Select a title to jump to the article. |
- Happy
holidays from all of us at IAC
- CDC
issues ACIP recommendations for preventing tetanus, diphtheria, and
pertussis in adults and the ACIP/HICPAC recommendations for healthcare
personnel
- VIS
translations: VISs for influenza vaccines now in Arabic; interim VIS for
HPV vaccine now in Thai
-
Submissions for Moorehouse's Best Practices for Eliminating Adult
Immunization Disparities contest due January 19, 2007
- Reminder:
Be sure to continue administering influenza vaccines throughout December
and into 2007
- CDC
reports on influenza vaccination coverage among children ages 6-23 months
during the 2005-06 influenza season
- CDC
reports that 56 percent of children under age six participated in
Immunization Information Systems in 2005
- December
22 is the deadline for submitting abstracts for the 2007 Northwest
Immunization Conference
- CDC
reports on U.S. public health surveillance for smallpox during 2003-05
|
| |
| Abbreviations |
|
|
AAFP, American Academy
of Family Physicians; AAP, American Academy of Pediatrics; ACIP, Advisory
Committee on Immunization Practices; CDC, Centers for Disease Control
and Prevention; FDA, Food and Drug Administration; IAC, Immunization
Action Coalition; MMWR, Morbidity and Mortality Weekly Report; NIP, National
Immunization Program; VIS, Vaccine Information Statement; VPD, vaccine-preventable
disease; WHO, World Health Organization. |
| |
|
Issue 637: December 18, 2006 |
|
|
|
1. |
Happy holidays from all of us at IAC
All of us at IAC wish the readers of IAC Express
a safe, happy, and relaxing holiday season—free from influenza.
This is our last issue for 2006. We'll email you the next issue on January 2,
2007.
Back to top |
| |
|
|
2. |
CDC issues ACIP recommendations
for preventing tetanus, diphtheria, and pertussis in adults and the ACIP/HICPAC
recommendations for healthcare personnel
CDC published "Preventing Tetanus, Diphtheria, and Pertussis Among Adults:
Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis
Vaccine: Recommendations of the Advisory Committee on Immunization Practices
(ACIP) and Recommendation of ACIP, Supported by the Healthcare Infection
Control Practices Advisory Committee (HICPAC), for Use of Tdap Among
Healthcare Personnel" in the December 15 issue of MMWR Recommendations and
Reports. The summary is reprinted below.
On June 10, 2005, a tetanus toxoid, reduced diphtheria toxoid,
and acellular pertussis vaccine (Tdap) formulated for use in
adults and adolescents was licensed in the United States for
persons aged 11-64 years (ADACEL, manufactured by sanofi
pasteur, Toronto, Ontario, Canada). Prelicensure studies
demonstrated safety and efficacy, inferred through
immunogenicity, against tetanus, diphtheria, and pertussis when
Tdap was administered as a single booster dose to adults. To
reduce pertussis morbidity among adults and maintain the
standard of care for tetanus and diphtheria prevention and to
reduce the transmission of pertussis to infants and in health-care settings, the Advisory Committee on Immunization Practices
(ACIP) recommends that: (1) adults aged 19-64 years should
receive a single dose of Tdap to replace tetanus and diphtheria
toxoids vaccine (Td) for booster immunization against tetanus,
diphtheria, and pertussis if they received their last dose of Td >=10 years earlier and they have not previously received Tdap;
(2) intervals shorter than 10 years since the last Td may be
used for booster protection against pertussis; (3) adults who
have or who anticipate having close contact with an infant aged
<12 months (e.g., parents, grandparents aged <65 years, child-care providers, and healthcare personnel) should receive a
single dose of Tdap to reduce the risk for transmitting
pertussis. An interval as short as 2 years from the last Td is
suggested; shorter intervals can be used. When possible, women
should receive Tdap before becoming pregnant. Women who have not
previously received Tdap should receive a dose of Tdap in the
immediate postpartum period; (4) healthcare personnel who work
in hospitals or ambulatory care settings and have direct patient
contact should receive a single dose of Tdap as soon as feasible
if they have not previously received Tdap. An interval as short
as 2 years from the last dose of Td is recommended; shorter
intervals may be used. These recommendations for use of Tdap in
healthcare personnel are supported by the Healthcare Infection
Control Practices Advisory Committee (HICPAC). This statement
(1) reviews pertussis, tetanus, and diphtheria vaccination
policy in the United States; (2) describes the clinical features
and epidemiology of pertussis among adults; (3) summarizes the
immunogenicity, efficacy, and safety data of Tdap; and (4)
presents recommendations for the use of Tdap among adults aged
19-64 years. . . .
To access a ready-to-print (PDF) version ACIP's adult Tdap
recommendations, which includes Appendices A, B, and C, go to:
http://www.cdc.gov/mmwr/PDF/rr/rr5517.pdf
Note: The PDF version includes a free CDC-sponsored education
activity that can be completed online or submitted by U.S. mail
for CME, CEU, CNE, CHES, or CPE credit. Simply read the primer,
answer the questions at the end, and follow instructions for
submitting your answers.
If you prefer the HTML version, you must access all four links
below to get the full content:
To access a web-text (HTML) version of the body of the
recommendations, go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5517a1.htm
To access a web-text (HTML) version of Appendix A: Summary of
Recommendations for Tetanus Toxoid, Reduced Diphtheria Toxoid,
and Acellular Pertussis Vaccine (Tdap) Use Among Adults, go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5517a2.htm
To access a web-text (HTML) version of Appendix B: CDC and
Council of State and Territorial Epidemiologists (CSTE)
Pertussis Case Definition, go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5517a3.htm
To access a web-text (HTML) version of Appendix C: Abbreviations
Used in This Report, go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5517a4.htm
To receive a FREE electronic subscription to MMWR (which
includes new ACIP statements), go to:
http://www.cdc.gov/mmwr/mmwrsubscribe.html
Back to top |
| |
|
|
3. |
VIS translations: VISs for
influenza vaccines now in Arabic;
interim VIS for HPV vaccine now in Thai
Dated 6/30/06, the current version of the VISs for trivalent
inactivated influenza vaccine (TIV; injectable) and live
attenuated intranasal vaccine (LAIV; nasal spray) are now
available on the IAC website in Arabic. Dated 9/5/06, the
interim VIS for human papillomavirus (HPV) vaccine is now
available in Thai. IAC gratefully acknowledges the California
Department of Health Services for the Arabic translations and
Asian Pacific Health Care Venture, Inc., for the Thai
translation.
VIS FOR TIV
To obtain a ready-to-print (PDF) version of the VIS for TIV in
Arabic, go to: http://www.immunize.org/vis/ab_flu06.pdf
To obtain it in English, go to:
http://www.immunize.org/vis/#influenza
VIS FOR LAIV
To obtain a ready-to-print (PDF) version of the VIS for LAIV in
Arabic, go to: http://www.immunize.org/vis/abLAIV06.pdf
To obtain it in English, go to:
http://www.immunize.org/vis/liveflu.pdf
INTERIM VIS FOR HPV VACCINE
To obtain a ready-to-print (PDF) version of the interim VIS for
HPV vaccine in Thai, go to:
http://www.immunize.org/vis/th_hpv.pdf
To obtain it in English, go to:
http://www.immunize.org/vis/vis-hpv-gardasil.pdf`
For information about the use of VISs, and for VISs in more than
30 languages, visit IAC's VIS web section at
http://www.immunize.org/vis
Back to top |
| |
|
|
4. |
Submissions for Moorehouse's
Best Practices for Eliminating
Adult Immunization Disparities contest due January 19, 2007
The Moorehouse School of Medicine recently announced its first
Call for Best Practices in Eliminating Adult Immunization
Disparities contest. The deadline for submissions is January 19,
2007.
The goal of the contest is to share and recognize effective
adult immunization projects and programs that have had success
in reducing racial, ethnic, and socioeconomic disparities in
adult influenza and pneumococcal vaccinations. The practices
submitted for consideration should be adaptable to other
organizations and must have achieved specific, measurable
results. The best practices selected will be stored with open
access to other adult immunization projects and programs.
For comprehensive information about the contest and an
application form, go to: http://www.msm.edu/ncpc and click on
the words "Learn More."
Back to top |
| |
|
|
5. |
Reminder: Be sure to continue
administering influenza
vaccines throughout December and into 2007
Remember, influenza vaccination should continue through the
month of December and beyond! Visit the following websites often
to find the information you need to keep vaccinating. Both are
continually updated with the latest resources.
The National Influenza Vaccine Summit website at
http://www.preventinfluenza.org
CDC's Influenza web section at http://www.cdc.gov/flu
Back to top |
| |
|
|
6. |
CDC reports on influenza
vaccination coverage among children
ages 6-23 months during the 2005-06 influenza season
CDC published "Brief Report: Influenza Vaccination Coverage
Among Children Aged 6-23 Months—Six Immunization Information
System Sentinel Sites, United States, 2005-06 Influenza Season"
in the December 15 issue of MMWR. The introductory paragraph is
reprinted below.
Beginning with the 2004-05 influenza season, the Advisory
Committee on Immunization Practices (ACIP) recommended that all
children aged 6-23 months receive influenza vaccinations
annually. Other children recommended to receive influenza
vaccinations include those aged 6 months-18 years who have
certain high-risk medical conditions, those on chronic aspirin
therapy, those who are household contacts of persons at high
risk for influenza complications, and, since 2006, all children
aged 24-59 months. Previously unvaccinated children aged <9
years need 2 doses administered at least 1 month apart to be
considered fully vaccinated. This report assesses influenza
vaccination coverage among children aged 6-23 months during the
2005-06 influenza season by using data from six immunization
information system (IIS) sentinel sites. The findings
demonstrate that vaccination coverage with 1 or more doses
varied widely (range: 6.6% to 60.4%) among sites, with
coverage increasing from the preceding influenza season in four
of the six sites. However, <23% of children in five of the sites
were fully vaccinated, underscoring the need for increased
measures to improve the proportion of children who are fully
vaccinated. . . .
To access a web-text (HTML) version of the complete article, go
to: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5549a4.htm
To access a ready-to-print (PDF) version of this issue of MMWR,
go to: http://www.cdc.gov/mmwr/PDF/wk/mm5549.pdf
Back to top |
| |
|
|
7. |
CDC reports that 56 percent of
children under age six
participated in Immunization Information Systems in 2005
CDC published "Immunization Information Systems Progress—United
States, 2005" in the December 15 issue of MMWR. The introductory
paragraph is reprinted below.
Immunization registries are confidential, computerized
information systems that collect and consolidate vaccination
data from multiple healthcare providers, generate reminder and
recall notifications, and assess vaccination coverage within a
defined geographic area. A registry with added capabilities,
such as vaccine management, adverse event reporting, lifespan
vaccination histories, and linkages with electronic data
sources, is called an immunization information system (IIS).
This report summarizes data from CDC's 2005 Immunization
Information System Annual Report (IISAR), a survey of grantees
in 50 states, five cities, and the District of Columbia (DC)
that receive funding under section 317b of the Public Health
Service Act. These data indicated that approximately 56% of U.S.
children aged <6 years participated in an IIS, an increase from
48% in 2004. Moreover, 75% percent of public vaccination
provider sites and 44% of private vaccination provider sites
submitted vaccination data to an IIS during July-December 2005.
These findings underscore the need to increase the number of
participating children, from the current 13 million to
approximately 21 million, to assure 95% participation of
children aged <6 years and improve the effectiveness of U.S.
immunization programs. . . .
To access a web-text (HTML) version of the complete article, go
to: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5549a3.htm
To access a ready-to-print (PDF) version of this issue of MMWR,
go to: http://www.cdc.gov/mmwr/PDF/wk/mm5549.pdf
Back to top |
| |
|
|
8. |
December 22 is the deadline
for submitting abstracts for the
2007 Northwest Immunization Conference
December 22 is the deadline for submitting abstracts for the
2007 Northwest Immunization Conference. Scheduled for May 15-16,
the conference will be held in Portland, OR.
For information on abstract submission, go to:
https://www.regonline.com/setup/custImages/241929/2007%20Call%20.doc
To submit an abstract online, go to:
https://www.regonline.com/setup/custImages/241929/abstract%20submit%202007.doc
For comprehensive information on the conference, go to:
http://www.regonline.com/Checkin.asp?EventId=105809
Back to top |
| |
|
|
9. |
CDC reports on U.S. public health
surveillance for smallpox during 2003-05
CDC published "Public Health Surveillance for Smallpox—United
States, 2003-2005" in the December 15 issue of MMWR. A portion
of the press summary is reprinted below.
Recommendations are made for continued advancement of disease
reporting, early event detection systems, and targeted training.
Several factors have contributed to the ability of state health
departments to conduct surveillance and respond to suspected
smallpox cases. These factors include new reporting requirements
and surveillance systems, access to local and reference
laboratory facilities, modes of communication to receive
information, and training of public health professionals and
healthcare practitioners. The findings from the CSTE [Council of
State and Territorial Epidemiologists] survey show that, in the
event of suspected smallpox, the public health infrastructure
has the key components in place to detect, receive reports of,
investigate, and confirm or rule out the disease.
To access a web-text (HTML) version of the complete article, go
to: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5549a2.htm
To access a ready-to-print (PDF) version of this issue of MMWR, go to:
http://www.cdc.gov/mmwr/PDF/wk/mm5549.pdf
Back to top |
| |
|
|
